HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RAGenome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathwaysAtherosclerosis in psoriatic disease: latest evidence and clinical implicationsSystematic review of the quality of prognosis studies in systemic lupus erythematosusRecent advances in understanding and managing psoriatic arthritisThe relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort studyFactors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortGenome-wide association analysis identifies three psoriasis susceptibility lociGenome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at RELInteraction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients.Psoriatic Arthritis.Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review.Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseasesIdentification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related lociClinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsDEVELOPING AN IPADĀ® APPLICATION FOR DATA COLLECTION IN A RHEUMATOLOGY RESEARCH CLINIC.Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort.Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.A family study of the antiphospholipid syndrome associated with other autoimmune diseases.Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.Mortality related to cerebrovascular disease in systemic lupus erythematosus.Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study.Vascular- and pregnancy-related outcomes in patients with systemic lupus erythematosus with positive antiphospholipid profile and thrombocytopenia.Defining Low Disease Activity in Systemic Lupus Erythematosus.Lupus pregnancy. A prospective study of placental changes.Systemic lupus erythematosus in males.The significance of thrombocytopenia in systemic lupus erythematosus.Haemostatic abnormalities in systemic lupus erythematosus.Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations.Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosusVenous syndromes and pulmonary embolism in systemic lupus erythematosus.
P50
Q24514792-BD66037F-B5A2-4AAA-992B-8F351309EF54Q24653432-0054D822-5ACB-4790-A6B6-EA461B52C67DQ26783501-304C2D46-9091-4559-ADF0-D468388EEF85Q26823668-208CAC87-05BE-490F-AFED-065DA1DD822BQ28076527-7EDA6A2C-9EC9-42ED-A5B3-C0642F87B1B8Q28212163-84FF78F1-576E-4FF7-9870-E47B7022B067Q28608340-F9DE2451-5E6A-4B1C-AE60-08A5DF7EF01DQ28924376-BC03E490-154B-4FC4-92E1-1B950C59E867Q28943423-82453E80-B08D-4DB5-BF59-7167777BB349Q29417082-8E4911CD-1675-4FC4-B2B4-5F8D9C481E5CQ30235042-00FC9042-F63B-498B-9660-36A8593C739AQ30235385-06E21492-71C5-4519-B3F4-71B664DC3068Q30249314-B0F152F0-4270-4BC4-B3AD-95D8734AA844Q30278872-2DCB453A-8632-4E40-8A7C-76DD599202FFQ30417517-0102B920-4D9D-4092-8C1A-C54974E80AC7Q30560952-B528A01A-1EE6-4681-A8C6-A84F633F6D7CQ30791606-1BB515C8-69E4-4B7B-9DD2-9D0C21CF8447Q30823425-BDFCFB1B-9518-4A4E-80E1-626383377C10Q30841346-46212190-9673-4083-84DD-AA5A3789BF55Q30955200-E63B5E4F-4A1C-47C6-AA82-95121F37A045Q31096607-202DF4C9-708D-44B7-893C-8315D2401E90Q31122937-73E7B2A1-F4CF-4559-B957-87C81317D43CQ31145074-91ACB999-9FF9-4483-BF39-D43B0193B227Q31169591-84E9A1D1-5D7F-4C1B-852D-A5BA5031A21FQ33333698-F22D6865-BFEF-4787-83C7-C74166652BCFQ33356141-52204081-47D0-4119-8733-6611F2E5C39CQ33358541-5F3D9115-B39E-4560-9306-BF65B8191E66Q33373805-41BC2F6A-3A79-44B0-BAB5-0E47D798AA67Q33400371-ACD7E8D7-5B16-4C1C-8FCC-9C5E0E3E9E57Q33406223-EED93045-4938-4158-8923-F1D90AEEBBECQ33419495-3EF21F9E-6F02-4FF0-8E07-25D48E5B3781Q33435736-6D82D41F-D92E-41E0-9FA1-EB990C72A31EQ33447262-3B7796B2-4799-4958-92E3-6DB7558980ECQ33476416-14F3F8E0-2A1B-45F3-81BA-67284ABA9AEDQ33480020-F160B74A-6CA0-45D5-82C3-26166203A91DQ33480156-76319BAC-EF6F-44BF-9F01-D39CE542BDD7Q33487732-45A6EB32-2C81-4FB6-83FB-F3203A4387EAQ33488402-3F582E59-08E3-40B3-8050-E0B2103CF79CQ33551533-6EC5DD6B-7B7C-478B-9A7A-AD22EB23D77AQ33552588-3785B559-BA9D-46AF-9B4A-260A569AAF32
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
Õ°Õ„ÕæÕ”Õ¦ÕøÕæÕøÕ²
@hy
name
Dafna D. Gladman
@ast
Dafna D. Gladman
@da
Dafna D. Gladman
@de
Dafna D. Gladman
@en
Dafna D. Gladman
@es
Dafna D. Gladman
@fo
Dafna D. Gladman
@fr
Dafna D. Gladman
@is
Dafna D. Gladman
@kl
Dafna D. Gladman
@nb
type
label
Dafna D. Gladman
@ast
Dafna D. Gladman
@da
Dafna D. Gladman
@de
Dafna D. Gladman
@en
Dafna D. Gladman
@es
Dafna D. Gladman
@fo
Dafna D. Gladman
@fr
Dafna D. Gladman
@is
Dafna D. Gladman
@kl
Dafna D. Gladman
@nb
altLabel
Dafna Gladman
@da
Dafna Gladman
@de
Dafna Gladman
@en
prefLabel
Dafna D. Gladman
@ast
Dafna D. Gladman
@da
Dafna D. Gladman
@de
Dafna D. Gladman
@en
Dafna D. Gladman
@es
Dafna D. Gladman
@fo
Dafna D. Gladman
@fr
Dafna D. Gladman
@is
Dafna D. Gladman
@kl
Dafna D. Gladman
@nb
P244
P106
P21
P213
0000 0003 7222 9093
P214
2219148947754554950003
P244
n2008037693
P31
P4012
P496
0000-0002-9074-0592
P734
P735
P7859
lccn-n2008037693